Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis
Clinical trial NCT05740722 · RECRUITING
Trial details
- NCT number
- NCT05740722
- Sponsor
- Haukeland University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2027-08-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.